Supplementary scales for the school-age forms of the Achenbach System of Empirically Based Assessment rated by adolescents, parents, and teachers: Psychometric properties in German samples
, , et
05 mai 2025
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 05 mai 2025
Pages: 30 - 43
DOI: https://doi.org/10.2478/sjcapp-2025-0004
Mots clés
© 2025 Julia Plück et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Scale scores and internal consistencies in clinic and community sample across informants
CBCL/6–18 | YSR/11–18 | TRF/6–18 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinic | Community | Clinic | Community | Clinic | |||||||||||||||||||
Age (years) | |||||||||||||||||||||||
M | 11.5 | 12.3 | 14.0 | 13.9 | 10.9 | ||||||||||||||||||
(3.3) | (3.3) | (2.1) | (2.2) | (3.1) | |||||||||||||||||||
Male% | 64.7 | 50.5 | 56.4 | 51.4 | 69.9 | ||||||||||||||||||
Scale | ( |
Ω | SD | Ω | ( |
Ω | Ω | ( |
Ω | ||||||||||||||
SPS | (14) | .72 | (.18-.50) | 9.07 | 4.56 | .74 | (.29-.44) | 2.86 | 2.90 | (14) | .79 | (.23-.61) | 8.89 | 5.02 | .78 | (.26-50) | 4.57 | 3.81 | (13) | .69 | (.21-.53) | 5.98 | 4.14 |
OCP | (8) | .69 | (.26-.51) | 3.18 | 2.86 | .54 | (.19-.37) | 0.80 | 1.27 | (8) | .74 | (.33-.55) | 3.92 | 3.37 | .64 | (.23-.44) | 1.56 | 1.96 | (8) | .66 | (.26-.45) | 1.82 | 2.36 |
SCT |
(4) | .66 | (.34-.54) | 1.79 | 1.77 | .50 | (.27-.33) | 0.51 | 0.91 | (5) | .81 | (.47-.66) | 2.73 | 2.65 | |||||||||
PQS |
(14) | .73 | (.14-.47) | 18.83 | 4.37 | .87 | (.29-.68) | 17.09 | 6.19 | ||||||||||||||
DRS1 | (41) | .89 | (.14-.60) | 24.32 | 12.22 | .89 | (.19-.53) | 8.31 | 7.57 | (39) | .89 | (.20-.63) | 21.33 | 11.34 | .91 | (.22-.58) | 12.71 | 9.51 | (62) | .95A | (-.02-.71) | 30.79 | 20.59 |
DRS2 | 24.30 | 11.98 | 8.23 | 7.54 | 22.11 | 11.61 | 12.93 | 9.71 | 29.08 | 19.52 | |||||||||||||
ASD1 | (9) | .58 | (.13-.43) | 3.56 | 2.81 | .52 | (.15-.33) | 0.98 | 1.42 | (9) | .51 | (.12-.31) | 3.57 | 2.70 | .56 | (.22-.33) | 1.65 | 1.89 | (9) | .63 | (.15-.48) | 2.77 | 2.67 |
ASD2 | (10) | .64 | (.20-.43) | 3.99 | 3.13 | .60 | (.20-.37) | 1.08 | 1.59 | (9) | .58 | (.22-.39) | 3.97 | 2.88 | .60 | (.23-.37) | 1.82 | 1.99 | (10) | .74 | (.29-.53) | 3.74 | 3.48 |
ASD31 | (15) | .78 | (.21-.55) | 6.76 | 4.87 | .76 | (.19-.46) | 1.97 | 2.63 | (14) | .72 | (.18-.45) | 6.69 | 4.37 | .75 | (.22-.45) | 3.40 | 3.30 | (15) | .80 | (.22-.59) | 6.02 | 4.95 |
MAS1 | (19) | .79 | (.13-.59) | 8.26 | 5.25 | .76 | (.13-.49) | 2.73 | 3.04 | (17) | .75 | (.19-.46) | 7.94 | 4.78 | .81 | (.21-.49) | 4.93 | 4.13 | (15) | .87 | (.03-.73) | 6.07 | 5.35 |
Mean differences between clinic and community samples for the CBCL/6–18 and YSR/11–18_
CBCL/6–18 | YSR/11–18 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Origin |
Clinic |
Community |
Clinic |
Community |
||||||||||
Scale | ||||||||||||||
SPS | 9.07 | 4.56 | 2.86 | 2.90 | 44.42 | 1843.22 | 1.75 | 8.89 | 5.02 | 4.57 | 3.81 | 21.24 | 1135.13 | 1.03 |
OCP | 3.18 | 2.86 | 0.80 | 1.27 | 28.43 | 1558.42 | 1.21 | 3.92 | 3.37 | 1.56 | 1.96 | 17.96 | 974.37 | 0.96 |
SCT |
1.79 | 1.77 | 0.51 | 0.91 | 24.25 | 1649.10 | 1.00 | |||||||
PQS |
18.83 | 4.37 | 17.09 | 6.19 | 8.02 | 1974.84 | 0.30 | |||||||
DRS1 | 24.32 | 12.22 | 8.32 | 7.57 | 42.92 | 1816.33 | 1.70 | 21.33 | 11.34 | 12.71 | 9.51 | 18.35 | 1220.90 | 0.85 |
DRS2 | 24.30 | 11.98 | 8.23 | 7.54 | 43.80 | 1831.65 | 1.73 | 22.11 | 11.62 | 12.93 | 9.71 | 19.09 | 1217.43 | 0.89 |
ASD1 | 3.56 | 2.81 | 0.98 | 1.42 | 30.99 | 1640.01 | 1.29 | 3.57 | 2.70 | 1.65 | 1.89 | 17.77 | 1077.19 | 0.89 |
ASD2 | 3.99 | 3.13 | 1.08 | 1.59 | 31.34 | 1638.54 | 1.30 | 3.97 | 2.88 | 1.82 | 1.99 | 18.74 | 1069.62 | 0.94 |
ASD3 | 6.76 | 4.87 | 1.97 | 2.63 | 32.84 | 1686.72 | 1.34 | 6.69 | 4.37 | 3.40 | 3.30 | 18.59 | 1131.57 | 0.90 |
MAS | 8.26 | 5.25 | 2.73 | 3.04 | 34.83 | 1748.99 | 1.40 | 7.94 | 4.78 | 4.93 | 4.13 | 15.09 | 1249.71 | 0.69 |
Mean differences of supplementary scales between clinic subgroups with and without the nearest respective diagnosis1
Scale | Group | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OCP | Y | 74 | 6.85 | 3.37 | - | 78.70 | <.001 | 1.44 | 62 | 6.95 | 3.62 | - | 753 | <.001 | 1.02 | 32 | 3.25 | 2.27 | -3.52 | 834 | <.001 | 0.64 |
N | 1214 | 2.96 | 2.67 | 9.77 |
693 | 3.65 | 3.22 | 7.67 | 804 | 1.76 | 2.34 | |||||||||||
ASD1 | Y | 68 | 6.96 | 3.48 | - | 71.36 | <.001 | 1.33 | 29 | 5.14 | 3.17 | - | 753 | .001 | 0.61 | 53 | 5.57 | 3.01 | -8.16 | 834 | <.001 | 1.16 |
N | 1220 | 3.37 | 2.64 | 8.37 |
726 | 3.50 | 2.66 | 3.22 | 783 | 2.58 | 2.54 | |||||||||||
ASD2 | Y | 68 | 7.79 | 3.60 | - | 1286 | <.001 | 1.34 | 29 | 5.10 | 3.31 | - | 753 | .030 | 0.41 | 53 | 7.43 | 4.05 | - | 56.74 | <.001 | 1.18 |
N | 1220 | 3.78 | 2.96 | 10.74 | 726 | 3.92 | 2.85 | 2.17 | 783 | 3.49 | 3.29 | 6.93 |
||||||||||
ASD3 | Y | 68 | 12.24 | 4.96 | -9.87 | 1286 | <.001 | 1.23 | 29 | 8.59 | 4.62 | - | 753 | .017 | 0.45 | 53 | 10.25 | 5.58 | -6.60 | 834 | <.001 | 0.94 |
N | 1220 | 6.45 | 4.69 | 726 | 6.61 | 4.34 | 2.39 | 783 | 5.73 | 4.77 |
Pearson Correlations of supplement scales with age and gender within both samples for each informant
CBCL/6–18R | YSR/11–18R | TRF/6–18R | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Origin | Clinic | Community | Clinic | Community | Clinic | ||||||
1288 | 2471 | 755 | 1797 | 836 | |||||||
455 | 1224 | 326 | 874 | 251 | |||||||
833 | 1247 | 429 | 923 | 585 | |||||||
Scale | |||||||||||
SPS | Age | .06 | [.00, .11] | -.01 | [-.05, .03] | .21 |
[.14, .28] | .06 | [.01, .10] | .07 | [<.01, .14] |
Gender |
.06 | [<.01, .12] | .01 | [-.03, .05] | .29 |
[.22, .35] | .08 |
[.04, .13] | -.08 | [-.15, -.02] | |
OCP | Age | .11 |
[.05, .16] | .05 | [<.01, .09] | .27 |
[.20, .33] | .11 |
[.06, .15] | .06 | [<-.01, .13] |
Gender | .12 |
[.07, .18] | .01 | [-.03, .05] | .32 |
[.26, .38] | .07 |
[.02, .11] | .02 | [-.05, .08] | |
SCT |
Age | .09 |
<-.01 | [-.06, .05] | - | - | .08 | [.01, .14] | |||
Gender | <.01 | [-.05, .06] | -.02 | [-.06, .02] | - | - | -.09 |
[-.16, -.02] | |||
PQS |
Age | - | - | -.10 |
[-.17, -.03] | .12 |
[.08, .17] | - | |||
Gender | - | - | -.04 | [-.11, .03] | .07 |
[.03, .12] | - | ||||
DRS1 | Age | -.10 |
[-.15, -.05] | -.04 | [-.08, <-.01] | .16 |
[.09, .23] | .06 | [.01, .10] | -.11 |
[-.17, -.04] |
Gender | -.15 |
[-.20, -.09] | -.07 |
[-.11. -.03] | .18 |
[.11, .24] | .04 | [-.01, .08] | -.27 |
[-.33, -.20] | |
DRS2 | Age | -.09 |
[-.14, -.03] | -.04 | [-.08, <.01] | .15 |
[.08, .22] | .04 | [<-.01, .09] | -.09 |
[-.16, -.02] |
Gender | -.15 |
[-.20, -.10] | -.07 |
[-.11, -.03] | .18 |
[.11, .24] | .04 | [-.01, .08] | -.24 |
[-.31, -.18] | |
ASD1 | Age | .04 | [-.01, .10] | -.02 | [-.06, .02] | .18 |
[.11, .25] | .02 | [-.02, .07] | -.01 | [-.08, .06] |
Gender | -.06 | [-.12, -.01] | -.01 | [-.05, .03] | .15 |
[.08, .22] | .06 | [<.01, .10] | -.14 |
[-.21, -.07] | |
ASD2 | Age | .07 |
[.02, .13] | .01 | [-.03, .05] | .24 |
[.18, .31] | .08 |
[.03, .12] | .01 | [-.05, .08] |
Gender | -.03 | [-.08, .03] | -.03 | [-.07, .01] | .18 |
[.11, .25] | .07 |
[.02, .11] | -.11 |
[-.18, -.04] | |
ASD3 | Age | .08 |
[.03, .13] | -.01 | [-.05, .03] | .27 |
[.20, .34] | .07 |
[.02, .11] | .04 | [-.03, .11] |
Gender | .01 | [-.05, .07] | <.01 | [-.04, .04] | .20 |
[.13, .27] | .07 |
[.03, .12] | .08 | [-.15, -.01] | |
MAS | Age | -.20 |
[-.25, -.14] | -.07 |
[-.11, .03] | .07 | [< -.01, .14] | .06 |
[.02, .11] | -.15 |
[-.21, -.08] |
Gender | -.25 |
[-.30, -.19] | -.10 |
[-.14, -.06] | .07 | [<.01, .14] | -.02 | [-.07, .02] | -.28 |
[-.34, -.22] |
Cross-informant Pearson correlations in community and clinic sample_
Community | Clinic | |||||||
---|---|---|---|---|---|---|---|---|
CBCLxYSR | CBCLxYSR | CBCLxTRF | TRFxYSR | |||||
1757 | 705 | 799 | 396 | |||||
Scale | ||||||||
SPS | .50 | [.47,.54] | .35 | [.28,.41] | .20 | [.13,.27] | .09 |
[-.01,.18] |
OCP | .35 | [.31,.39] | .41 | [.35,.47] | .20 | [.14,.27] | .21 | [.12,.30] |
SCT |
- | .33 | [.26,.39] | - | - | |||
DRS1 | .53 | [.50,.57] | .34 | [.27,.40] | .35 | [.29,.41] | .15 | [.05,.24] |
DRS2 | .53 | [.48,.56] | .33 | [.26,.39] | .33 | [.27,.39] | .14 | [.04,.23] |
ASD1 | .39 | [.35,.43] | .33 | [.26,.40] | .35 | [.28,.41] | .19 | [.10,.29] |
ASD2 | .38 | [.34,.42] | .30 | [.24,.37] | .35 | [.29,.41] | .13 | [.04,.23] |
ASD3 | .44 | [.41,.48] | .34 | [.27,.41] | .38 | [.32,.44] | .19 | [.09,.28] |
MAS | .46 | [.42,.50] | .36 | [.29,.42] | .40 | [.34,.46] | .25 | [.15,.34] |